Susan Hasty, Publisher
Table of Contents . . . January 9th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Vaccine Weekly | Other Publications
AIDS and HIV Vaccine - Modified Rhabdovirus Makes Effective Vector
Tumor Recurrence - Fibroblasts Useful Vectors For Gene Delivery After Surgical Injury
Colon Cancer - Ridding Cells Of Heat Shock Protein 70 Enhances Tumor Immunogenicity
Pediatrics - Pentavalent Vaccine Could Weaken Hepatitis B Vaccination Efforts
Tuberculosis - Study Measures Economic Benefits Of TB Vaccine
Vaccine Adjuvants - Transduced Dendritic Cells Inspire Antitumor Effect
AIDS Therapies - Protein Sciences Gets NIAID Contract For AIDS Vaccines
AIDS and HIV Vaccine - Resistant Genotypes Can Confound Research
Acute Myelogenous Leukemia - Encouraging Results From Phase I Trial Of GVAX Cancer Vaccine
Acute Myeloid Leukemia - Positive Phase III Clinical Results With Humanized Antibody Therapy
Ethics - AAMC Issues New Guidelines On Financial Conflicts Of Interest
HIV Vaccines - Imperial College, Chelsea, Westminster Healthcare To Coordinate Trials
Malaria - Mosquito-Borne Malady May Be Made More Deadly
Measles - U.S. Trial Starts For Recombinant Human Albumin Vaccines
Mergers - MedImmune Gets FluMist Rights In Agreement With Aviron
Prostate Cancer - Monoclonal Antibody Therapy Looks Promising
Psoriasis - SkyePharma And Astralis Enter Agreements For Promising New Treatment
Rheumatoid Arthritis - HuMax-CD4 To Enter Phase III Studies
Smallpox - Family Recalls Smallpox Claiming Mom, Says Vaccinations Should Resume
Smallpox - National Vaccine Information Center Releases Smallpox Report Opposing Forced Vaccination Plan
Streptococcus Pneumoniae - New Child Vaccine in High Demand
Vaccine Technology - Gold Powder Might Replace Needle-Sticks In The Future
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.